Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews
Submission Deadline: 31 Jul 2023
Guest Editor
Faculty of Medicine, Macau University of Science and Technology, Taipa, Macau, China
Interests: the pathogenesis and treatment of hyperlipidaemia; hypertension; the metabolic syndrome and diabetes the clinical pharmacology; toxicology and pharmacogenetics of drugs; particularly in the cardiovascular field
Special Issues in IMR Press journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to provide a comprehensive overview of the state-of-the-art regarding atherosclerosis and cardiovascular diseases in Asia. We invite research papers that will consolidate our understanding in this area. The Special Issue will publish full research articles and systematic reviews. Potential topics include, but are not limited to, the following research areas:
• atherosclerosis
• cardiovascular diseases and risk factors
• cerebrovascular diseases
• coronary artery disease
• inflammation
• high blood pressure and lipids
• cardiovascular outcomes
• diagnosis and prevention
• cardiovascular imaging
• treatments for cardiovascular diseases and risk factors
It is my pleasure to invite you to submit manuscripts on the topic of “Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the Art Reviews” for this Special Issue. Comprehensive reviews, as well as systematic reviews, are welcome. Please feel free to contact me, the guest editor, in case of further questions.
Prof. Brian Tomlinson
Guest Editor
Keywords
- atherosclerosis
- cardiac arrhythmias
- cerebrovascular disease
- chronic heart failure
- coronary heart disease
- diabetes
- hypertension
- lipids
- obesity
Published Papers (10)
Coronary Artery Calcium Score–Weighted Clinical Likelihood Model Performance in Patients with Stable Chest Pain and Coronary Artery Calcium Scores of Zero
Rev. Cardiovasc. Med. 2024, 25(3), 85; https://doi.org/10.31083/j.rcm2503085
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)
Current Anticoagulation Statuses among Older Chinese People with Nonvalvular Atrial Fibrillation
Rev. Cardiovasc. Med. 2024, 25(3), 79; https://doi.org/10.31083/j.rcm2503079
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)
Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease
Rev. Cardiovasc. Med. 2023, 24(11), 314; https://doi.org/10.31083/j.rcm2411314
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)
Characteristics, Treatment, and Mortality of Patients Hospitalized for First ST-Segment Elevation Myocardial Infarction without Standard Modifiable Risk Factors in China
Rev. Cardiovasc. Med. 2023, 24(9), 249; https://doi.org/10.31083/j.rcm2409249
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)
The Effectiveness and Safety of Intensive Lipid-Lowering with Different Rosuvastatin-Based Regimens in Patients at High Cardiovascular Disease Risk: A Nonblind, Randomized, Controlled Trial
Rev. Cardiovasc. Med. 2023, 24(8), 222; https://doi.org/10.31083/j.rcm2408222
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)
Effects of 12 Weeks of Resistance Training on Body Composition, Muscle Hypertrophy and Function, Blood Lipid Level, and Hemorheological Properties in Middle-Aged Obese Women
Rev. Cardiovasc. Med. 2023, 24(7), 196; https://doi.org/10.31083/j.rcm2407196
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)
Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
Rev. Cardiovasc. Med. 2023, 24(6), 173; https://doi.org/10.31083/j.rcm2406173
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)
The Value of RBP4 in Assessing Coronary Artery Elasticity in Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus
Rev. Cardiovasc. Med. 2023, 24(2), 33; https://doi.org/10.31083/j.rcm2402033
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)
Omega-3 Polyunsaturated Fatty Acids Supplements and Cardiovascular Disease Outcome: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
Rev. Cardiovasc. Med. 2023, 24(1), 24; https://doi.org/10.31083/j.rcm2401024
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)
NHHR: An Important Independent Risk Factor for Patients with STEMI
Rev. Cardiovasc. Med. 2022, 23(12), 398; https://doi.org/10.31083/j.rcm2312398
(This article belongs to the Special Issue Atherosclerosis and Cardiovascular Diseases in Asia: State-of-the-Art Reviews)